Nisityotakul Panat, Rookkapan Sorracha
Department of Radiology, Vachira Phuket Hospital, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
J Korean Soc Radiol. 2024 May;85(3):596-606. doi: 10.3348/jksr.2023.0116. Epub 2024 Apr 29.
To examine the technical considerations of endovascular treatment for aortoiliac occlusive disease (AIOD) based on a 10-year experience in Songklanagarind Hospital.
This retrospective cohort study included 210 patients who underwent endovascular treatment for symptomatic AIOD between January 2010 and December 2020. The patients' clinical and lesion characteristics, including technical considerations of the procedure, were collected, analyzed, and stratified using the Transatlantic Inter-Society Consensus (TASC).
Most patients (80%) in this study had chronic limb-threatening ischemia lesions, with an occlusion rate of 37%. The technical success rate of TASC C & D was lower than that of TASC A & B, 84.4% vs. 99.2% ≤ 0.001. A technical success rate of 93.3% (14/15) was found for the femoral and brachial approach, compared with a success rate of 89.0% (57/64) for the unibifemoral approach in TASC C & D, without a statistically significant difference ( = 0.076). However, the puncture site complications in this route were up to 17.6%, which is the highest rate compared with other techniques. These complications could be treated either conservatively or minimally invasively.
In cases of failed femoral access, simultaneous femoral and brachial approaches improved the technical success rate of endovascular recanalization of TASC C & D aortoiliac occlusions.
基于宋卡那加拉医院10年的经验,探讨主髂动脉闭塞性疾病(AIOD)血管内治疗的技术要点。
这项回顾性队列研究纳入了2010年1月至2020年12月期间接受有症状AIOD血管内治疗的210例患者。收集、分析患者的临床和病变特征,包括手术的技术要点,并根据跨大西洋两岸协会共识(TASC)进行分层。
本研究中大多数患者(80%)患有慢性肢体威胁性缺血病变,闭塞率为37%。TASC C和D级病变的技术成功率低于TASC A和B级病变,分别为84.4%和99.2%,P≤0.001。股动脉和肱动脉联合入路的技术成功率为93.3%(14/15),而TASC C和D级病变中单侧股动脉入路的成功率为89.0%(57/64),差异无统计学意义(P = 0.076)。然而,该入路的穿刺部位并发症高达17.6%,是所有技术中发生率最高的。这些并发症可以通过保守治疗或微创治疗。
在股动脉穿刺失败的情况下,股动脉和肱动脉联合入路可提高TASC C和D级主髂动脉闭塞血管内再通的技术成功率。